Anthem Blue Cross (HMO, PPO, EPO)
Xalkori (crizotinib)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: PA_APPLIES
  • Step Therapy: Diabetic Medical Supplies:
    ST Multiple Brands

  • Quantity Limit: 4 tablets per 1 day(s).
  • Quantity Limit: limit maximum 6 EA PER 1 day(s)
  • Chorea in Huntington's Disease:
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A

    Tardive Dyskinesia (TD):
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: Unspecified
    AIMS Score: N/A
    Patient Must Not Have Congenital LQTS or Arrhythmias Associated with Prolonged QT Interval: No
    Patient Must Not Have Risk of Suicidal Behavior and Unstable Psychiatric Symptoms: No
    Concomitant Use With Other VMAT inhibitors Prohibited: No
    Supporting Documentation Requirements: 1 of Lab Tests;Medication History